Introducing the First ADAMTS-13 Screening Assay

Posted: December 3, 2018

New Biomarkers for Liver and Kidney Toxicity Studies

Technoscreen® ADAMTS-13 Activity

Technoscreen ADAMTS13 Assay Principle

NEW! Technoscreen® ADAMTS-13 Activity is a semiquantitative flow through assay for the determination of ADAMTS-13 activity levels in plasma.

  • Screening tool for estimating ADAMTS-13 activity in clinical research studies – deficiency of ADAMTS-13 needs confirmed by a quantitative system
  • Using an easy, fast in-house screening assay can lead to significant cost savings in clinical research studies
  • Rapid screening with ready to use reagents
  • Reduced 30-minute time to results
  • Large and small pipettes included
  • Color chart included, for easy interpretation of results
  • No instrumentation required

Click here for more info

Research use only in the U.S. and Canada

New Biomarkers for Liver and Kidney Toxicity Studies

Diapharma Group, Inc., 8948 Beckett Rd., West Chester, OH 45069